Inventor · disambiguated record
Weng K. Chang
Also filed as: CHANG WENG · CHANG WENG K
5 granted patents·8 pending applications·7 citations·filing 2021–2025
70Inventor score
Files withGILEAD SCIENCES INC13
Top patents by PatentIndex Score
13 records- 0193US11976083B2Inhibitors of peptidylarginine deiminasesGILEAD SCIENCES INC·Filed 2021·Granted May 7, 2024·3 cites·15 claims
- 0292US12091420B2SARS-COV2 main protease inhibitorsGILEAD SCIENCES INC·Filed 2023·Granted Sep 17, 2024·3 cites·28 claims
- 0390US12410183B2Sars-cov2 main protease inhibitorsGILEAD SCIENCES INC·Filed 2024·Granted Sep 9, 2025·1 cites·25 claims
- 0475US2025049780A1Thienopyrrole compoundsGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 0575US2024239807A1Sars-cov2 main protease inhibitorsGILEAD SCIENCES INC·Filed 2023·Application pending·0 cites
- 0673US12070455B2Thienopyrrole compoundsGILEAD SCIENCES INC·Filed 2022·Granted Aug 27, 2024·0 cites·29 claims
- 0769US11661431B2Thienopyrrole compoundsGILEAD SCIENCES INC·Filed 2022·Granted May 30, 2023·0 cites·53 claims
- 0869US2023365594A1Thienopyrrole compoundsGILEAD SCIENCES INC·Filed 2023·Application pending·0 cites
- 0958US2024217990A1Thienopyrrole compoundsGILEAD SCIENCES INC·Filed 2022·Application pending·0 cites
- 1057US2024059673A1Substituted indole compoundsGILEAD SCIENCES INC·Filed 2021·Application pending·0 cites
- 1157US2025002471A16-substituted indole compoundsGILEAD SCIENCES INC·Filed 2021·Application pending·0 cites
- 1247US2025276979A1Sars-cov2 main protease inhibitorsGILEAD SCIENCES INC·Filed 2025·Application pending·0 cites
- 1345US2025296936A1Sars-cov2 main protease inhibitorsGILEAD SCIENCES INC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Weng K. Chang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →